Autologous Cytokine-Induced Killer Cell Immunotherapy Enhances Chemotherapy Efficacy against Multidrug-Resistant Tuberculosis

Table 4

Basic data of the serology and immunology test of patients.

Clinical test indexes	CIK plus ()			Chemo-mono ()			value
			Min~max			Min~max
WBC (10^9/L)	9		4~7.7	9		3.6~8.1	0.936
Hb (10^9/L)	9		100~159	9		103~131	0.141
PLT (10^9/L)	9		75~291	9		139~399	0.109
N0 (10^9/L)	9		53.4~84.7	9		49.9~88.8	0.855
L0 (10^9/L)	9		6.9~41	9		5.7~34.8	0.646
ALT5	9		3~324	9		7~24	0.183
AST5	9		9~206	9		8~27	0.186
TB (μmol/L)	9		4.9~32	9		4.7~13.1	0.176
DB (μmol/L)	9		1.6~12.2	9		1.7~5.1	0.134
ALG (g/L)	9		33.9~50.8	9		32.5~43	0.248
BUN (mmol/L)	9		2.18~6.09	9		1.69~5.48	0.554
UA (μmol/L)	9		296.6~679.7	9		217.8~666.3	0.032
Cr (μmol/L)	9		37.8~76.9	9		36.9~69.8	0.147
T (%)	9		33.3~88	8		51.5~85.3	0.247
CD4^+T (%)	9		21~52	8		25~48	0.759
CD8^+T (%)	9		11~44	8		18~42	0.14
B (%)	9	12.24±4.95	5~23	8		10~20	0.187
NK (%)	9		953	8		335	0.318
CD4/CD8	9		0.68~2.38	8		0.72~1.78	0.1
L/CD45 (%)	9		9.13~38.91	8		10.18~36.51	0.673
CD14/CD45 (%)	9		4.43~19.95	8		6.16~15.14	0.589
CD8^+CD28^+/CD3^+ (%)	8		8.51~27.91	8		14.75~36.67	0.028
CD4^+CD28^-/CD3^+ (%)	8		0.53~13.47	8		0~4.58	0.339
CD8^+CD28^-/CD3^+ (%)	8		5.92~45.22	8		4.27~29.88	0.525
CD4^+CD28^+/CD3^+ (%)	8		33.78~69.03	8		37.87~58.94	0.569
CD4^+CD25^hi/CD3^+ (%)	8		5.91~19.97	8		6.39~20.82	0.751
IL-1β (pg/mL)	6		5~5	5		5~5	—
IL-2R (U/mL)	6		631~2572	5		701~1852	0.74
IL-6 (pg/mL)	6		4~35	5		5~18	0.693
IL-8 (pg/mL)	6		5~20	5		8~27	0.567
IL-10 (pg/mL)	6		5~6.9	5		5~5	0.214
TNF-α (pg/mL)	6		6~47.9	5		8~24	0.824
PCT (ng/mL)	6		0.02~0.51	5		0.03~0.13	0.543

WBC: white blood cell; Hb: hemoglobin; PLT: blood platelet; NO: nitric oxide; LO: liquid oxygen; ALT: alanine aminotransferase; AST: aspartate transaminase; TB: tuberculosis; DB: direct bilirubin; ALG: antilymphocyte globulin; BUN: blood urea nitrogen; UA: urinalysis; Cr: creatinine; L: lymphocyte; PCT: procalcitonin.